FC
RDY icon

Financial Consulate’s Dr. Reddy's Laboratories RDY Stock Holding History

Financial Consulate’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6K Sell
1,839
-1,551
-46% -$20.9K ﹤0.01% 469
2026
Q1 		$47K Buy
3,390
+1,830
+117% +$25.5K 0.01% 339
2025
Q4 		$21.9K Buy
1,560
+60
+4% +$842 ﹤0.01% 456
2025
Q3 		$21K Buy
+1,500
New +$21.6K ﹤0.01% 441

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Financial Consulate's RDY Position: Q2 2026 in Review

Financial Consulate reduced its Dr. Reddy's Laboratories (RDY) stake by 46% in Q2 2026, selling an estimated $20.9K and leaving 1,839 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

Financial Consulate first reported a position in RDY in Q3 2025 and has held it in 4 quarters since. The position peaked at $47K in Q1 2026. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Financial Consulate held 1,839 shares of Dr. Reddy's Laboratories worth $26.6K as of Q2 2026.
  • Financial Consulate sold 1,551 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $20.9K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #469 holding.
  • Financial Consulate first reported a position in Dr. Reddy's Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Financial Consulate's Dr. Reddy's Laboratories position peaked at $47K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.